ENSG

Healthcare services company The Ensign Group (NASDAQ:ENSG) fell short of the market’s revenue expectations in Q3 2026, but sales rose 14.5% year on year to $1.48 billion.

Ensign Group has delivered a strong run over the past few years, and the share price now reflects a lot of optimism. The live question is whether that price is in line with the cash flows the business is expected to generate.

The Ensign Group’s third quarter drew a positive market reaction despite missing Wall Street’s revenue and earnings per share expectations, as investors looked beyond headline numbers to underlying business momentum.

CEO Barry Port discusses record Q3 revenue and raised guidance.

The Ensign Group (NASDAQ:ENSG) raised its 2026 earnings outlook after reporting third-quarter revenue and earnings growth, supported by higher occupancy, skilled-nursing mix and acquisitions.

Shares of healthcare services company The Ensign Group (NASDAQ:ENSG) jumped 9.3% in the afternoon session after the company reported third-quarter adjusted diluted earnings per share above analyst estimates and raised its full-year earnings per share guidance.

(AP) — SAN JUAN CAPISTRANO, Calif. (ENSG) on Tuesday reported profit of $104.

Moby summary of The Ensign Group, Inc.'s Q3 2026 earnings call

Although the revenue and EPS for Ensign Group (ENSG) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Investing.com -- The Ensign Group Inc (NASDAQ:ENSG) reported third-quarter adjusted earnings per share of $2.03, beating analyst estimates of $1.97, though revenue of $1.48 billion fell short of the $1.51 billion consensus.

Ensign Group (ENSG) delivered earnings and revenue surprises of +4.64% and -0.71%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?